Siladitya Ray, Forbes Staff

Author's posts

Moderna’s Covid-19 Vaccine Is More Than 94% Effective, Preliminary Data Shows

Pfizer announced last week that its vaccine has shown 90% efficacy in preventing the disease.

State-Backed Russian, North Korean Hackers Targeting Covid-19 Vaccine Research, Microsoft Alleges

The company is urging world leaders to target actors facilitated by nation-states.

Brazil Suspends Trials Of China’s Covid-19 Vaccine After ‘Serious Adverse Event’

The vaccine maker claims that the incident has nothing to do with the vaccine.

Biden’s New Covid-19 Task Force, Staffed By Health Experts, To Meet As U.S. Approaches 10 Million Cases

The task force will be co-chaired by officials from the Obama, Bush and Clinton administrations.

Day After Election, U.S. Records All-Time High Of 103,000 New Covid-19 Cases

On average the U.S. is reporting nearly 89,000 new Covid-19 cases per day.

China Reports Highest Number Of Asymptomatic Cases Since April Following Outbreak In Xinjiang

The country has tested 2.84 million people in the Kashgar region of Xinjiang since Saturday.

OxyContin Maker Purdue Pharma Reaches $8 Billion Settlement In Opioid Crisis Probe

The drugmaker has also pleaded guilty to three federal charges regarding its role in the crisis.

U.K. Government Invests $43 Million In Vaccine Trials That Deliberately Infect Volunteers With Covid-19

The “human challenge” trials may help establish the efficacy of Covid-19 vaccines faster.

U.K. Government Reportedly In Advanced Talks To Initiate Human Challenge Vaccine Trials That Would See Volunteers Infected With Covid-19

British biotech firm hVIVO is in talks to create and provide strains of the Covid-19 virus which can be used for human challenge trials.

Russia Approves Second Covid-19 Vaccine — Before Phase-III Trials Even Start

The vaccine has only been tested in a small-scale trial with 100 volunteers, results of which are yet to be made available.